A study to evaluate the effects of test food on reducing body fat - A study to evaluate the effects of test food on reducing body fat

ROHTO Pharmaceutical Co.,Ltd.0 sites80 target enrollmentDecember 12, 2023

ConditionsHealthy volunteers

Overview

Phase: 未知
Intervention: Not specified
Conditions: Healthy volunteers
Sponsor: ROHTO Pharmaceutical Co.,Ltd.
Enrollment: 80
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

December 12, 2023

End Date

December 31, 2022

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

ROHTO Pharmaceutical Co.,Ltd.

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1\) Subjects receiving a medical treatment for serious cardio\-vascular, hepatic, renal, respiratory, endocrine or metabolic disorders or having a medical history of these disorders 2\) Subjects receiving a medical treatment for chronic diseases (dyslipidemia, high blood pressure, diabetes, etc.) 3\) Subject who have mental diseases such as depression, schizophrenia and bulimia nervosa. 4\) Subjects who take regularly medicines and quasi\-drugs having the effects on visceral fat, triglycerides, body weight, cholesterol, energy metabolism, etc. 5\) Subjects who take regularly health food (Food for Specified Health Uses, Food with Functional Claims, etc.) having the effects on visceral fat, triglycerides, body weight, cholesterol, energy metabolism, etc. 6\) Subjects who have the possibility of developing allergic symptoms by the test food 7\) Subjects who have metallic device in the abdominal CT scan area 8\) Subjects who have implantable medical device (cardiac pacemaker, implantable cardioverter defibrillator, etc.) 9\) Subjects who have claustrophobia 10\) Subjects who have smoking habit 11\) Subjects who routinely drink a lot (60 g/day or more as pure alcohol) 12\) Subjects who have an extremely irregular diet habit 13\) Subjects who are alternative workers, or work on midnight shift 14\) Subjects having blood sample of 200 ml or more taken within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood) 15\) Subjects who took part in another clinical study within 4 months prior to the start of the present study or who is currently taking part in another clinical study 16\) Subjects who are pregnant or lactating, or intending to become pregnant during the study 17\) Subjects deemed unsuitable by the investigator